The expression of genes encoding enzymes involved in de novo triglyceride synthesis (lipogenesis) is transcriptionally induced in the liver in response to increased glucose metabolism. The carbohydrate response element-binding protein (ChREBP) is a newly identified basic helix-loop-helix/leucine zipper transcription factor proposed to regulate the expression of the glucoseresponsive gene pyruvate kinase. This gene contains a carbohydrate response element (ChoRE) consisting of two E box motifs separated by 5 bp that is necessary and sufficient for glucose regulation. We demonstrate that overexpression of ChREBP in primary rat hepatocytes activates other ChoRE-containing promoters in a manner consistent with their ability to respond to glucose. In vitro binding of ChREBP to ChoRE sequences was not detected. Because E box-binding proteins function as obligate dimers, we performed a yeast two-hybrid screen of a mouse liver cDNA library to identify potential heteromeric partners. Mlx (Max-like protein X) was selected as the only basic helix-loop-helix/leucine zipper interaction partner in this screen. When a plasmid expressing either Mlx or ChREBP was cotransfected with a ChoRE-containing reporter plasmid into human embryonic kidney 293 cells, no increase in promoter activity was observed. However, the expression of both proteins dramatically enhanced promoter activity. This activation was observed with reporters containing ChoREs from several different lipogenic enzyme genes. In contrast, reporters containing non-glucose-responsive E box elements were not activated by ChREBP-Mlx expression. In vitro binding of ChREBP to ChoRE-containing oligonucleotides was observed only in the presence of Mlx. ChREBP-Mlx binding discriminated between E box sites that are glucose-responsive and those that are not. We conclude that Mlx is a functional heteromeric partner of ChREBP in regulating the expression of glucose-responsive genes.
The expression of genes encoding enzymes involved in de novo triglyceride synthesis (lipogenesis) is transcriptionally induced in the liver in response to increased glucose metabolism. The carbohydrate response element-binding protein (ChREBP) is a newly identified basic helix-loop-helix/leucine zipper transcription factor proposed to regulate the expression of the glucoseresponsive gene pyruvate kinase. This gene contains a carbohydrate response element (ChoRE) consisting of two E box motifs separated by 5 bp that is necessary and sufficient for glucose regulation. We demonstrate that overexpression of ChREBP in primary rat hepatocytes activates other ChoRE-containing promoters in a manner consistent with their ability to respond to glucose. In vitro binding of ChREBP to ChoRE sequences was not detected. Because E box-binding proteins function as obligate dimers, we performed a yeast two-hybrid screen of a mouse liver cDNA library to identify potential heteromeric partners. Mlx (Max-like protein X) was selected as the only basic helix-loop-helix/leucine zipper interaction partner in this screen. When a plasmid expressing either Mlx or ChREBP was cotransfected with a ChoRE-containing reporter plasmid into human embryonic kidney 293 cells, no increase in promoter activity was observed. However, the expression of both proteins dramatically enhanced promoter activity. This activation was observed with reporters containing ChoREs from several different lipogenic enzyme genes. In contrast, reporters containing non-glucose-responsive E box elements were not activated by ChREBP-Mlx expression. In vitro binding of ChREBP to ChoRE-containing oligonucleotides was observed only in the presence of Mlx. ChREBP-Mlx binding discriminated between E box sites that are glucose-responsive and those that are not. We conclude that Mlx is a functional heteromeric partner of ChREBP in regulating the expression of glucose-responsive genes.
Triglycerides are the principal energy storage fuel in mammals. The synthesis of triglycerides in the liver is regulated by the nutrition of the animal. For example, when mammals are fed a high carbohydrate/low fat diet, increases in insulin and in glucose uptake and metabolism occur in response to elevated blood glucose levels. These changes are responsible for increasing the production of triglycerides in the liver. The increased production is due to modifications of both the concentration and activity of enzymes involved in the pathway of triglyceride synthesis (lipogenesis). The induction of lipogenic enzyme genes occurs primarily at the transcriptional level. Lipogenic mRNAs that are induced in response to high carbohydrate feeding include pyruvate kinase (PK), 1 fatty-acid synthase, acetyl-CoA carboxylase, S 14 , and stearoyl-CoA desaturase (for review, see Refs. [1] [2] [3] .
The basic helix-loop-helix/leucine zipper (bHLH/LZ) transcription factor sterol regulatory element-binding protein-1c (SREBP-1c) plays a critical role in the insulin-dependent induction of lipogenic genes (for review, see Refs. 4 -6) . SREBP-1c expression is induced by insulin (7) (8) (9) , and it is capable of binding to sequences in the promoters of several lipogenic enzyme genes to induce their expression (10 -12) . Also, transgenic mice with liver-specific overexpression of SREBP-1c have an increased rate of lipogenesis as well as increased levels of lipogenic mRNAs (13, 14) . However, we have provided evidence that SREBP-1c expression is not sufficient to account for the glucose/insulin induction of lipogenic enzyme genes in primary rat hepatocytes (15, 16) . Therefore, we proposed the existence of another factor, carbohydrate-responsive factor (ChoRF), that is responsible for the glucose induction of lipogenic enzyme genes. A sequence in the PK promoter has been identified for its ability to support a response to glucose (17) (18) (19) . This DNA element is designated a carbohydrate response element (ChoRE) and consists of two 5Ј-CACGTG type E box motifs separated by 5 bp. Similar ChoREs have been identified in the promoters of the fatty-acid synthase, S 14 , and acetyl-CoA carboxylase genes (20 -23) . In the case of both the fatty-acid synthase and S 14 genes, independent sites for the actions of insulin (SREBP-1c-binding site) and glucose (presumptive ChoRF-binding site) have been identified (16, 22, 24) . These sites act synergistically to support the actions of glucose and insulin.
Recently, a transcription factor has emerged as a candidate for the ChoRF (25) (26) (27) . This protein, carbohydrate response element-binding protein (ChREBP), was purified based on its ability to bind the PK ChoRE in DNA affinity chromatography (25) . ChREBP (also known as WBSCR14 and MondoB) is a member of the bHLH/LZ family of transcription factors that is known to recognize E box sequences in the promoters of target genes. ChREBP mRNA is present in mouse kidney, heart, and small intestine, but predominantly in the liver (25, 28) . When primary rat hepatocytes are transfected with a ChREBP expression vector, PK promoter activity is increased under high (but not low) glucose conditions (25) . It remains to be seen whether ChREBP can activate other lipogenic enzyme gene promoters and whether it binds to the regulatory sequences in these lipogenic genes.
In this study, we present further evidence supporting the role of ChREBP in the induction of transcription in glucoseresponsive promoters. In addition, we found that ChREBP does not act alone, but instead functions in a heteromeric complex with the bHLH/LZ transcription factor Mlx (Max-like protein X). Together, these two bHLH/LZ factors bind to and activate transcription in a number of lipogenic enzyme genes containing the ChoRE.
EXPERIMENTAL PROCEDURES
Cloning of ChREBP-The full-length ChREBP-isoform (GenBank TM /EBI accession number AF245475) was cloned by PCR using the Expand High Fidelity PCR kit (Roche Applied Science), mouse liver cDNA as template, and primers with restriction enzyme tags (forward, 5Ј-GGAAGATCTATGGCGCGCGCGCTGGCGGATCT-3Ј; and reverse, 5Ј-GACAAGCTTGCTTGGAAACTTTCACCAGG-3Ј). ChREBP was cloned into the CMVS4 expression plasmid (29) using the BglII/HindIII sites. Because of its instability in other strains, this plasmid was prepared in large scale using Escherichia coli Stbl2 cells (Invitrogen). The double mutant ChREBP was prepared by subcloning ChREBP into the pTZ18R vector (Promega) and mutating Ser 196 and Thr 666 to alanines using the QuikChange TM site-directed mutagenesis kit (Stratagene) and previously published primers (26) . The FLAG epitope tag was inserted at the 5Ј-end of both wild-type and double mutant ChREBPs in the pTZ18R vector using the QuikChange TM site-directed mutagenesis kit (see Ref. 30 for FLAG sequence).
Primary Hepatocyte Culture and Transfections-Male Harlan Sprague-Dawley rats (200 -300 g) were fed ad libitum, and primary hepatocytes were isolated by the collagenase perfusion method described previously (31) . After a 3-h attachment to 35-mm Primaria plates, cells were transiently transfected using F1 reagent (Targeting Systems, San Diego, CA) in Williams' E medium containing 5.5 mM glucose, 23 mM HEPES, 0.01 M dexamethasone, 2 mM glutamine, 50 units/ml penicillin, 50 g/ml streptomycin, 26 mM sodium bicarbonate, and 0.1 unit/ml insulin. Plasmids were used at 2 g of reporter and 500 ng of total expression vector (empty CMVS4 vector ϩ expression vector containing the gene of interest) per 35-mm plate. After overnight transfection, cells were washed and cultured in the same medium containing either 5.5 or 27.5 mM glucose for 24 h. Hepatocytes were harvested using Promega reporter lysis buffer. Luciferase assays were performed using Promega luciferase assay substrate. Results of luciferase assays are expressed as relative light units/g of protein. Protein concentrations were determined using Bio-Rad protein assay reagent with bovine serum albumin as the standard.
293 Cell Culture and Transfections-Human embryonic kidney 293 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum and penicillin/streptomycin. For reporter assays, cells were transfected in 35-mm dishes using Opti-MEM and LipofectAMINE 2000 reagent (both from Invitrogen). Plasmids were used at 3.2 g of reporter plasmid and 800 ng of expression vector (empty CMVS4 vector ϩ expression vector containing the gene of interest) per 35-mm plate. After overnight transfection, cells were washed and cultured in Opti-MEM supplemented with 4% fetal bovine serum for 24 h. 293 cells were harvested, and luciferase assays were performed as described above.
To obtain whole cell extracts for electrophoretic mobility shift assays (EMSAs), 293 cells were transfected in 100-mm plates using the calcium phosphate method and 15 g of expression vector/plate. For those 293 cells that were cotransfected with both ChREBP and Mlx, 15 g of each vector was used. Briefly, the DNA was diluted into 450 l of water, and 50 l of 2.5 M CaCl 2 was added dropwise. In a separate tube, air was bubbled through 500 l of a HEPES-buffered saline solution (0.28 M NaCl, 50 mM HEPES, and 1.5 mM Na 2 HPO 4 , pH 7.05) while the CaCl 2 / DNA mixture was added to it dropwise. This transfection mixture was incubated at room temperature for 20 min and then added to the 293 cells. The whole cell lysate was extracted from cells 40 h post-transfection using the "whole cell extract" protocol in the nuclear extract kit from ActiveMotif (Carlsbad, CA).
Yeast Two-hybrid Assay-Yeast two-hybrid screening was performed using the Matchmaker Gal4 Two-Hybrid System 3 and a mouse liver cDNA library following the manufacturer's instructions (Clontech). The library was made from 200 male BALB/c mouse livers (9 -12 weeks old) and contained 3.5 ϫ 10 6 independent clones in the pACT2 vector. Two mouse ChREBP bait plasmids were prepared: one with amino acids 632-763 fused to the Gal4 DNA-binding domain and the other with amino acids 632-868. Transformation-scale screens were conducted in yeast strain AH109 at either medium (Ϫhistidine) or high (Ϫhistidine and Ϫadenine) stringency. Putative positive colonies were further streaked on Ϫadenine/5-bromo-4-chloro-3-indolyl ␣-D-galactopyranoside plates to confirm interaction. Yeast plasmids were prepped using the Zymoprep yeast plasmid miniprep kit (Zymo Research, Orange, CA). To isolate the library plasmid (pACT2), yeast plasmid preparations were transformed into E. coli DH5␣ cells and selected on ampicillin plates. The cDNA contained in the library plasmid was sequenced using the Matchmaker 5ЈAD LD-Insert Screening Amplimer primer (Clontech).
Cloning of Mlx Isoforms-Mlx␥ was cloned into the CMVS4 expression vector using the Expand High Fidelity PCR kit, a yeast two-hybrid screen plasmid as template, and primers with BglII or SalI restriction enzyme tags, respectively (forward, 5Ј-CACAGATCTATGACGGAGC-CGGGCGCCTC-3Ј; and reverse, 5Ј-ACGCGTCGACTCAGTAGAGTTG-GTTTTTCAACTG-3Ј). Mlx␤ was cloned by PCR using mouse cDNA and primers with BglII restriction enzyme tags (forward, 5Ј-CACAGATCT-ATGACGGAGCCGGGCGCCTC-3Ј; and reverse, 5Ј-GAAGATCTTCAG-TAGAGTTGGTTTTTCAACTG-3Ј). A hemagglutinin (HA) tag was added to the CMVS4/Mlx␥ vector using the QuikChange TM site-directed mutagenesis kit.
EMSAs-EMSAs were conducted as described previously (20) . A typical reaction contained 100,000 cpm of 32 P-labeled oligonucleotide and 5 g of whole cell extract from 293 cells. The nonspecific competitor used was 2 g of poly(dI-dC). Following incubation with oligonucleotide for 30 min at room temperature, samples were subjected to electrophoresis on a 4.5% nondenaturing polyacrylamide gel. Results were obtained from PhosphorImager analysis. For reactions with antibodies, proteins were preincubated with antibody for 30 min on ice before the 30-min room temperature incubation with oligonucleotide. Mouse anti-HA monoclonal antibody HA-7 and mouse anti-FLAG monoclonal antibody M2 (both from Sigma) were used. The catalytic subunit of protein phosphatase 2A (Upstate Biotechnology, Inc.) was preincubated with cell extract for 15 min at room temperature before addition of oligonucleotide.
RESULTS

Activation of Reporter Plasmids by ChREBP in Primary Rat
Hepatocytes Correlates with Glucose Responsiveness-As mentioned in the Introduction, ChREBP has been shown to activate transcription in the PK promoter under high glucose conditions in rat hepatocytes (25) . To further evaluate the role of ChREBP in the glucose regulation of ChoRE-containing promoters, we cotransfected ChREBP along with reporter plasmids containing mutant ChoREs with changes in the spacing between the two E box motifs. In all naturally occurring ChoREs characterized to date, a spacing of 5 bp is found between the two critical E boxes (32) . Mutants with a spacing of 6 bp between the two E box motifs are substantially reduced in their glucose response, whereas mutants with a 4-bp separation do not respond to glucose (21) . If ChREBP is the carbohydrate-responsive transcription factor, a correlation should exist between its ability to activate these mutant ChoREs and their ability to respond to glucose. Primary hepatocytes were cotransfected with the ChREBP expression vector and luciferase reporter plasmids containing the ChoRE spacing mutants and then cultured in low (5.5 mM) or high (27.5 mM) glucose. As predicted, overexpression of ChREBP did not affect the activity of any reporter construct under low glucose conditions (Fig. 1 ). In the presence of high glucose, ChREBP overexpression led to an increase (ϳ2-fold) in reporter activity in the construct with wild-type spacing (N5). ChREBP was able to slightly increase promoter activity above endogenous levels in the 6-bp spacing mutant (N6). However, addition of exogenous ChREBP did not increase promoter activity in the 4-bp spacing mutant (N4). Hence, ChREBP activation of these plasmids correlates with their ability to respond to glucose, further supporting the role of ChREBP in mediating the glucose response.
Mlx Isoforms Interact with ChREBP in a Yeast Two-hybrid Assay-EMSAs were conducted with in vitro transcribed/translated ChREBP to evaluate its binding to ChoRE-containing oligonucleotides. Efforts to detect ChREBP binding to multiple ChoRE-containing oligonucleotides were unsuccessful. Because all known bHLH/LZ proteins bind to DNA as dimers or tetramers, this suggested that ChREBP may form a heteromeric complex with a distinct bHLH/LZ family member in the liver to act as the ChoRF.
A yeast two-hybrid screen was carried out to identify potential liver heterodimeric partners for ChREBP. Using a mouse liver cDNA library and a fragment of ChREBP containing the bHLH/LZ domain as bait, 55 positive colonies were selected. Among these, Mlx was identified five times. Mlx is a bHLH/LZ family member of the Myc/Max/Mad subclass. Both Mlx␤ and Mlx␥ isoforms were represented in the positive clones. None of the other clones were found to be bHLH/LZ family members. Because the screen was performed for the purpose of identifying potential bHLH/LZ family partners, only Mlx was pursued in the following experiments. It remains to be seen whether the other ChREBP-interacting proteins are relevant to ChREBP function in vivo.
ChREBP and Mlx Bind to the PK ChoRE as a Heteromeric Complex-To investigate ChREBP and Mlx binding to ChoREcontaining oligonucleotides, we used whole cell extracts from 293 cells that were transfected with expression plasmids for these proteins. When whole cell lysates from untransfected 293 cells were incubated with a radiolabeled PK ChoRE oligonucleotide in an EMSA, two complexes were observed (Fig. 2, lane  2) . These complexes likely represent endogenous E box-binding proteins. Curiously, the more quickly migrating complex appeared to be variable in intensity in different preparations. When 293 cells were transfected with the HA-tagged Mlx␥ expression vector alone (lane 5), no additional protein-DNA complexes were formed. Likewise, transfection of FLAG-tagged ChREBP led to no additional complex formation (lane 6). In contrast, extracts from cells cotransfected with both HA-tagged Mlx␥ and FLAG-tagged ChREBP yielded a slower migrating complex (lane 8). This new complex was shifted with antibody to either the HA or FLAG tag (lanes 9 and 10), indicating the presence of both Mlx and ChREBP in the complex.
Kawaguchi et al. (26) recently presented evidence that phosphorylation of ChREBP plays an important role in DNA binding. Protein kinase A-dependent phosphorylation of Ser 196 represses nuclear translocation, whereas phosphorylation of Thr 666 inhibits the ability of a recombinant C-terminal region of ChREBP to bind to an E box-containing oligonucleotide. Also, the expression of a double mutant of ChREBP (S196A/ T666A) leads to increased PK promoter activity above wildtype ChREBP in primary rat hepatocytes treated with high glucose and cAMP. When this double mutant ChREBP was cotransfected with Mlx into 293 cells, the intensity of the newly formed complex was enhanced (Fig. 2, lane 11) . This complex was also shifted with antibody to either the HA or FLAG tag (lanes 12 and 13). Immunoblotting with 293 cell extracts confirmed that the expression of FLAG-tagged wild-type ChREBP and FLAG-tagged double mutant ChREBP was comparable and that their expression did not affect HA-tagged Mlx expression (data not shown). To verify that the increased binding of the double mutant ChREBP was due to decreased phosphorylation and not to an adventitious change in conformation, we EMSA was performed using the ChoRE oligonucleotide from the acetylCoA carboxylase gene promoter (see Fig. 7 ). evaluated the effect of phosphatase treatment on ChREBP binding (lanes 14 -19) . Treatment of extracts from 293 cells transfected with wild-type ChREBP and Mlx with the catalytic subunit of protein phosphatase 2A led to a progressive increase in binding to the ChoRE. This observation is consistent with the idea that wild-type ChREBP binding in 293 extracts is limited by an inhibitory phosphorylation event. Thus, formation of a protein complex on the PK ChoRE oligonucleotide requires the presence of both Mlx and ChREBP, and binding of ChREBP is inhibited by phosphorylation.
Coexpression of ChREBP and Mlx Is Capable of Inducing Transcription of Glucose-responsive Sequences-To test whether the ChREBP-Mlx complex is capable of activating transcription, cotransfection experiments with ChoRE-containing reporter plasmids were carried out in primary hepatocytes. Cotransfection of ChREBP and Mlx␥ expression vectors gave no increase in reporter activity above that seen with ChREBP alone (data not shown). It is possible that, in hepatocytes, Mlx is already at high levels and that further addition of Mlx cannot increase activity. For this reason, cotransfection experiments were conducted in 293 cells, a cell line that has no detectable Mlx protein (33) .
293 cells were cotransfected with a luciferase reporter plasmid containing two copies of the mut3/5 ChoRE linked to a basal promoter and an expression vector containing ChREBP and/or Mlx (␤ or ␥). The mut3/5 ChoRE is derived from the rat S 14 ChoRE and contains a degenerate E box (CAtGcG). It has previously been shown to support a strong response to glucose, but has decreased binding for the ubiquitously expressed upstream stimulatory factor and presumably other E box-binding proteins (31) . When 293 cells were transfected with an expression vector for either ChREBP or Mlx, no induction of reporter activity above basal levels was observed (Fig. 3) . In contrast, when expression vectors for both ChREBP and Mlx were cotransfected, there was a dose-dependent increase in reporter activity up to 8-fold higher than basal levels. No major difference in reporter activity was observed between cells transfected with the ␤-or ␥-isoform of Mlx. These data support an integral role for Mlx in the actions of ChREBP.
Binding and Activation of ChoRE Spacing Mutants by ChREBP and Mlx Correlate with Functional
Activity-To further evaluate whether ChREBP and Mlx function together in mediating the glucose response, an experiment was conducted with the panel of spacing mutant constructs described above. 293 cells were cotransfected with reporter plasmids containing the ChoRE spacing mutants and expression vectors containing ChREBP and Mlx␥. The 4-bp spacing mutant (N4), which did not respond to glucose, showed no increase in reporter activity above basal levels upon addition of ChREBP and Mlx (Fig. 4) . The wild-type spacing plasmid (N5), which did respond to glucose, showed a 4-fold induction upon addition of ChREBP and Mlx expression vectors. Finally, the 6-bp spacing mutant (N6), which had previously shown an intermediate response to glucose, showed a 2-fold induction above basal levels when cotransfected with ChREBP and Mlx. Consequently, the activation of these spacing mutants by ChREBP and Mlx shows the same pattern in 293 cells as the glucose responsiveness of these sequences in hepatocytes.
To investigate whether binding of ChREBP and Mlx correlates with activation, EMSAs were performed with oligonucleotides containing varied E box spacing (Fig. 5) . For this experiment, both wild-type and double mutant ChREBPs, which showed enhanced binding to the PK ChoRE, were used. . This is consistent with the inability of this sequence to respond to glucose. On the 6-bp spacing oligonucleotide, the slower migrating band of interest was observed only when cells were transfected with Mlx␥ and the double mutant ChREBP, suggesting a lower affinity of ChREBP-Mlx for this sequence, which is blunted in its response to glucose. Thus, both the binding of ChREBP-Mlx to spacing mutant constructs and the ability of ChREBP-Mlx to activate transcription in these constructs correlate with the potential of these sequences to support a glucose response.
ChREBP and Mlx Bind to and Activate Transcription in ChoREs from Other Lipogenic Enzyme Gene Promoters-Thus
far, we have shown that cotransfection of ChREBP and Mlx leads to increased promoter activity in constructs containing the PK ChoRE. If ChREBP and Mlx function together as the ChoRF, they should be able to activate ChoREs from other lipogenic enzyme gene promoters. To test this, we cotransfected ChREBP and Mlx␥ into 293 cells along with a panel of reporter constructs. Each of the reporter constructs contained two copies of a ChoRE upstream of a basal TATA box promoter from the PK gene (Ϫ40 to ϩ12). Consequently, this assay examined the ability of ChREBP-Mlx to activate in the absence of other transcription factor-binding sites. When transfected with any of the ChoREs from the S 14 , PK, and acetyl-CoA carboxylase lipogenic enzyme genes or with the synthetic mut3/5 ChoRE, there was a dramatic increase in reporter activity upon addition of ChREBP and Mlx (Fig. 6) . Sterol response element-1, a binding site for SREBP, was run as a negative control. This sequence does not respond to high glucose treatment in primary rat hepatocytes when linked to a basal promoter (16) . Additionally, the adenovirus upstream stimulatory factor construct also contains an E box sequence previously shown to be unresponsive to glucose (20) . Neither of these negative controls showed induction of activity above basal levels upon addition of ChREBP and Mlx. It was of interest, however, to observe the elevated basal level with the adenovirus upstream stimulatory factor construct. This sequence must provide a binding site for a transcription factor present in 293 cells. These experiments demonstrate that ChREBP-Mlx can activate transcription in lipogenic enzyme gene ChoREs and can distinguish E boxes that support a glucose response from those that do not.
To investigate whether ChREBP-Mlx can bind to the same sequences it activates, EMSAs were conducted using oligonucleotides corresponding to those tested functionally (Fig. 7) . Because of the increased sensitivity it offers, the double mutant ChREBP was used in this experiment. When 293 cells were transfected with the double mutant ChREBP and Mlx␥, a band not present in untransfected extract lanes was visible on all of the oligonucleotides that function as ChoREs. In contrast, this FIG. 5 . Binding of ChREBP-Mlx to spacing mutants correlates with activity. EMSA was performed as described under "Experimental Procedures" with 5 g of whole cell extract from 293 cells transfected with FLAG-tagged wild-type ChREBP (wtChREBP), FLAG-tagged double mutant ChREBP (dmChREBP), or HA-tagged Mlx␥ (Mlx) as indicated. Oligonucleotides contained the PK ChoRE with wild-type spacing between the E box motifs (L-type PK (L-PK) N5; lanes 1-6), 4-bp spacing (L-type PK N4; lanes 7-9), or 6-bp spacing (L-type PK N6; lanes 10 -12) as described previously (32) complex was not formed on an oligonucleotide containing the SREBP-binding site. This observation is consistent with the results in Fig. 6 demonstrating that cotransfection of ChREBP and Mlx did not activate a reporter construct with the sterol response element sequence. The WBSCR14 oligonucleotide contains a single perfect E box motif that was originally described for its ability to bind a C-terminal fragment of ChREBP and Mlx (34) . A unique complex was detected on this oligonucleotide in extracts transfected with both Mlx and ChREBP. However, this complex migrated more quickly than the complex that formed on the ChoRE oligonucleotides. This faster migrating complex was shifted by antibodies to both the HA and FLAG tags, indicating the presence of both Mlx and ChREBP (data not shown). Additional studies with this WB-SCR14 sequence indicated that it did not support a response to glucose in primary rat hepatocytes and was not activated by cotransfection of ChREBP and Mlx in a 293 cell reporter assay. 2 These results raise the possibility that, on ChoREs, ChREBP and Mlx form a functional heterotetrameric complex, whereas on the single E box WBSCR14 oligonucleotide, the complex that forms is a heterodimer of ChREBP and Mlx that is not functional in supporting transcriptional activation.
DISCUSSION
The identity of the ChoRF has remained elusive (31, (35) (36) (37) (38) (39) . Recent work by Uyeda and co-workers (25) has identified ChREBP as a candidate. ChREBP was isolated based on its ability to bind to the ChoRE in the PK promoter. ChREBP was found to be a member of the bHLH/LZ transcription factor family. Members of this family bind to E box sequences such as those present in the ChoRE of the PK promoter. Expression levels of the mRNA for ChREBP are highest in the liver, making this a reasonable candidate for the transcription factor responsible for carbohydrate induction of lipogenesis in the liver. Functional studies in primary rat hepatocytes demonstrated that overexpression of ChREBP activates transcription of the PK promoter in cells maintained in high (but not low) glucose (25) . However, this activation is modest at only 2-3-fold above induction by the endogenous factor. In addition, ChREBP overexpression leads to an increase in PK promoter activity in ␤-cell-derived INS-1 cells (40) . Thus far, functional evidence that ChREBP is the long sought ChoRF is dependent upon these studies with the PK promoter. It remains to be seen whether ChREBP acts on the other lipogenic enzyme promoters that are induced in response to a high carbohydrate diet.
In this study, we present evidence that ChREBP activates transcription in several other glucose-responsive sequences in addition to PK. For example, the series of spacing mutants, previously shown to have variable responses to glucose, followed the expected pattern of induction by ChREBP if it is indeed the ChoRF. To evaluate whether this functional activity correlated with binding, efforts to detect ChREBP homodimer formation on ChoRE-containing oligonucleotides in an EMSA were undertaken. No observable complex was present in an EMSA with in vitro transcribed/translated full-length ChREBP, suggesting that it does not bind as a homodimer. Consistent with this, ChREBP was not found to interact with itself in a yeast two-hybrid interaction assay (34) . Examination of literature demonstrating ChREBP binding to E box sequences revealed that all previous experiments were conducted with a fragment of ChREBP lacking the amino terminus (26, 34) . It is possible that sequences at the amino terminus of ChREBP are inhibitory to its binding to DNA as a homodimer.
A search was conducted for a distinct heteromeric partner for ChREBP. We were particularly interested in determining whether a liver-specific heteromeric partner might exist. For this reason, a yeast two-hybrid experiment was carried out with the bHLH/LZ domain of ChREBP as bait. In a mouse liver cDNA library, Mlx was identified as the only bHLH/LZ interaction partner. Although this screen was not exhaustive, the identification of Mlx five times suggests that Mlx is the predominant ChREBP partner in liver. Mlx has been previously shown to interact with ChREBP in other cell contexts (34) . Mlx was first identified as a Mad1-interacting protein by yeast two-hybrid screen (33) . Based on biochemical properties similar to Max, Mlx was proposed to be a common dimerization partner of a new transcription factor network. In addition to ChREBP, Mlx is also known to interact with Mad1, Mnt, and Mad4; however, no known target genes for these additional interaction partners have been identified (33, 41) . Mlx is a ubiquitously expressed member of the bHLH/LZ family of transcription factors. To determine whether ChREBP and Mlx can assemble a heteromeric complex and bind to oligonucleotides containing a ChoRE, EMSAs were conducted with sequences from the PK promoter. Only in the presence of both Mlx and ChREBP was a complex formed on the PK oligonucleotide. Additionally, binding of this complex was enhanced when a double mutant form of ChREBP was used in place of wild-type ChREBP. This double mutant has two alanine substitutions for protein kinase A-dependent phosphorylation residues. Studies conducted by Uyeda and co-workers (26) have suggested that these two phosphorylation sites are important in regulating the ability of ChREBP to enter the nucleus and to bind to DNA. Consistent with this, we have observed an increase in ChREBP-Mlx binding when cell extracts from 293 cells expressing wild-type ChREBP and Mlx were treated with protein phosphatase 2A.
If ChREBP and Mlx interact in vivo to form a functional complex, one might expect to observe a dramatic increase in the reporter activity of constructs containing a ChoRE in hepatocytes cotransfected with both ChREBP and Mlx. However, this increase was not observed. One likely explanation is that high endogenous levels of these proteins in the induced hepatocyte are sufficient to saturate the glucose response. Therefore, experiments were conducted in 293 cells, in which the Mlx expression is low (33) . In 293 cells, transfection of either ChREBP or Mlx alone did not induce transcription of ChoRE-containing reporter plasmids. Cotransfection of ChREBP and Mlx led to a dramatic induction in constructs containing glucose-responsive ChoREs, but not in those constructs containing E boxes that do not respond to glucose. To test whether binding correlated with functional data, we conducted EMSAs to determine whether ChREBP and Mlx assemble a heteromeric complex that binds oligonucleotides containing functional ChoREs from lipogenic enzyme gene promoters. We found that a complex of ChREBP and Mlx selectively bound to sequences that respond to glucose and not to similar sequences that do not respond to glucose. Thus, the results of this study provide evidence that ChREBP and Mlx form the functional ChoRF, which binds to and activates ChoREs in the promoters of lipogenic enzyme genes.
In contrast to these results, Cairo et al. (34) found that cotransfection of ChREBP and Mlx into 293 cells represses transcription. This study was carried out using a reporter construct with four copies of a consensus Myc/Max E box sequence. In mapping the domain critical for this repression by preparation of Gal4 fusion proteins, these authors detected separable repression and activation domains of ChREBP. Hence, the ability of ChREBP to act as a repressor or activator appears to depend on the context and/or organization of E box target sites. In this regard, it is worth noting that the ChREBPMlx complex that forms a functional ChoRF migrates more slowly than that observed on an oligonucleotide with a single E box site. This latter E box did not support a glucose response in hepatocytes even when inserted in multiple copies. We surmise that the ability of ChREBP-Mlx to activate may depend on the formation of a heterotetramer on ChoREs with a 5-bp spacing between E box sites. On oligonucleotides with a single E box, a heterodimer of ChREBP and Mlx forms, and this heterodimer may lead to the repression of transcription. This flexibility could serve to increase the regulatory potential of ChREBP following its activation by glucose. Clearly, further work will be necessary to test this possibility and to explore the molecular basis of the differential transcriptional effects of ChREBP-Mlx.
A critical question at this juncture is how ChREBP and Mlx are regulated by glucose metabolism. A recent study by Uyeda and co-workers (27) has proposed a role for xylulose 5-phosphate in the activation of ChREBP. Under high glucose conditions, increased glucose metabolism in the hepatocyte leads to accumulation of xylulose 5-phosphate. Xylulose 5-phosphate was found to activate a protein phosphatase 2A isoform. Dephosphorylation of Ser 196 , which is located near the nuclear localization signal, leads to translocation of ChREBP to the nucleus. Subsequently, dephosphorylation of Thr 666 enhances the ability of ChREBP to bind to DNA in the nucleus. Under low glucose conditions, however, glucagon-stimulated cAMP accumulation activates protein kinase A, which leads to phosphorylation of these residues and localization of ChREBP to the cytoplasm. Interestingly, this same xylulose 5-phosphate-activated protein phosphatase 2A has been found to activate the kinase activity of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (42) . This results in increased fructose 2,6-bisphosphate levels and elevated rates of glycolysis. Hence, the actions of glucose at the level of enzyme activation and gene transcription could be coupled.
One question that is raised by this intriguing model is how activation by ChREBP and Mlx occurs in the 293 cell. These cells are not glucose-responsive, as they lack the critical GLUT2/glucokinase couple that allows rates of glucose metabolism in the hepatocyte to be proportional to blood glucose levels. Based on the current model, it appears that a portion of the ChREBP exists in the dephosphorylated form in 293 cells due to low levels of cAMP and protein kinase A activity. However, given the stimulated binding observed with the double alanine mutant (S196A/T666A) or following phosphatase treatment of wild-type ChREBP, even in 293 cells, a portion of the ChREBP appears to be maintained in a phosphorylated and inactive state. We have also tested the double mutant ChREBP for its ability to activate in hepatocytes. The prediction of the model is that this form should be constitutively active in hepatocytes maintained in low glucose. However, we found that the double mutant ChREBP did not activate ChoRE-containing constructs under these conditions, although it was still capable of activating ϳ2-fold above endogenous levels in the presence of high glucose, similar to wild-type ChREBP.
2 Consistent with this, we have previously found that hepatocytes cultured under low glucose conditions with insulin, but no glucagon, do not induce ChoRE-containing promoters (20, 21) . Under these conditions, cAMP levels would be very low, and it is unlikely that protein kinase A would be activated. Hence, in addition to dephosphorylation of protein kinase A-mediated modifications, additional steps appear to be needed to activate ChREBP and/or Mlx under high glucose conditions.
